Osstem Implant Co., Ltd. signed a stock purchase agreement to acquire Implacil de Bortoli - Material Odontológico S.A. for $89.8 million on April 13, 2024. The deal is seen as Osstem Implant's Bolt-on strategy. Funding for the transaction is expected to be provided through surplus cash from Osstem Implant's U.S. subsidiary, Hiossen, and the deal closing is expected by the end of May.
Osstem Implant Co., Ltd.
Equities
A048260
KR7048260004
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
+10.24% | 128B | |
-8.89% | 11.26B | |
+3.31% | 9.28B | |
+35.16% | 5.42B | |
-23.90% | 4.8B | |
+8.20% | 3.45B | |
-10.69% | 2.8B | |
-12.15% | 2.1B | |
-11.96% | 1.98B |